Below is a summary of companies from the BioMedReports.com FDA Decision Date Calendar which have market caps below $200M, making them ideal candidates for extreme stock price volatility trades as their decision dates become imminent. Dyax Corp. (DYAX) secured a narrow approval from a FDA Advisory Panel in early February (with a 6-5-2 vote) for its Kalbitor (ecallantide or DX-88) BLA with a PDUFA date of 3/23/09, which is designated for priority review in the treatment of acute attacks of hereditary angioedema (HAE is a rare disorder marked by severe swelling which can be fatal if the throat area is involved). The panel debated the need for an effective treatment for this rare, potentially dangerous condition against the 3% higher incidence of allergic reactions (13% versus 10%) in patients taking[More...]
The accompanying table includes statistics for the 40 companies in the ETF Innovators Global Stem Cell and Regenerative Medicine Index, which is down 14.2% at a value of 3,387[More...]
The accompanying table (click to enlarge) includes 40 companies in the ETF Innovators Global Stem Cell and Regenerative Medicine Index, which represents an expansion of the Emerging Stem Cell Index I have written about previously. The expanded global index includes companies with market caps less than $1B at the index inception with a total market value of $3,814 as of the close[More...]
NOBL is one I’ve been trading and writing about—check out all the testimonials from TIMalert subscribers HERE…$4.80-$4.90 is support, if it cracks that, it could tank 50 cents or so, so far it’s been holding on…I doubt I’ll short this as it is an earnings play so no matter what happens, it really shouldn’t collapse quickly like pump and dumps doEVSO is a spmmaer goin higher, wasting an awful lo of volume though and still hasn’t broken out…hopefully these spammers are the real deal and can push this thing waaay up, I’ll probly wait til a confirmed breakout above $3 to buyPRS is a financial play going up gradually, two strikes against it, I’m not interested in shortingVUOC has been spiking from 50 cents/share to $1—they’ve supposedly developed energy[More...]
I know, I know you want some stock trades, well, it’s been boring, welcome to PennyStocking, there’s not gonna be a trade every day or even every week, especially during this, the slowest month of the year. Deal with it and don’t force trades…and most of all, stop emailing me about when … (visit site to read more)<img[More...]